GranuFlo Lawsuit Loans
In March 2012, the Food and Drug Administration (FDA) issued a Class I recall on dialysates GranuFlo and NaturaLyte, manufactured by Fresenius Medical Care. Both acid concentrate products were found to put patients at risk for cardiac arrest and other adverse events when administered in improper dosages. For hundreds of dialysis patients this recall came too late, and many suffered catastrophic injuries that have sparked litigation against Fresenius. GranuFlo and NaturaLyte have been blamed for incidents of heart attack, stroke, and sudden death among those who received it, prompting injured patients and their families to sue Fresenius on charges of failure to warn.
For many who suffered harm or the loss of a loved one, legal recourse is their only means of recouping compensation for medical bills and other damages. And while the products liability litigation drags out and expenses continue to pile up, many plaintiffs are considering the advantages of a GranuFlo lawsuit loan.
Basis for GranuFlo lawsuits
Fresenius Medical Care is the largest provider of hemodialysis products and services in the world and marketed NaturaLyte and GranuFlo – additives that help malfunctioning kidneys clean the blood – to both their own clinics and outside dialysis centers. Both products are formulated with higher concentrations of their active ingredient than most dialysates – a life-threatening factor when either is given in high doses. Unfortunately, health care providers were not informed of these risks, and the improper dosage of both products caused many patients to develop dangerously high bicarbonate levels, which often led to extremely low blood pressure, cardiac arrhythmia, and cardiopulmonary arrest.
Allegations raised in GranuFlo and NaturaLyte lawsuits say that Fresenius knew about the potentially life-threatening side effects of their hemodialysis additives yet failed to inform the medical community or public about these dangers. Claimants are also accusing the company of failing to adequately train dialysis center employees concerning the safe and proper use of both acid concentrates. Plaintiffs who have filed a case may want to consider applying for a Granuflo lawsuit loan to help keep them financially afloat during the sometimes lengthy litigation process.
Side effects linked to NaturaLyte and GranuFlo
Both NaturaLyte and GranuFlo are associated with the same harmful side effects when administered in high doses. While other dialysates are primarily made with acetic acid, NaturaLyte and GranuFlo contain acetic acid and sodium diacetate, which the body converts into bicarbonate – essentially raising bicarbonate levels beyond their normal levels. According to warnings issued by the FDA, excessive bicarbonate levels can lead to risk factors for the following complications:
- Cardiac arrhythmia
- Low blood oxygen pressure
- Low potassium levels in the blood
- Low blood pressure
- High concentrations of carbon dioxide in the blood
GranuFlo and NaturaLyte injuries
NaturaLyte and GranuFlo lawsuits allege that the products cause an increased risk of sudden death and cardiovascular injuries such as:
- Heart attack
- Cardiovascular problems
- Cardiopulmonary arrest
- Sudden death
FDA recall & allegations against Fresenius
An internal Fresenius memo dated November 4, 2011 that described 940 incidents of Granuflo-related heart attack was leaked to the FDA in early 2012, prompting the federal agency to investigate the manufacturer for fraudulent conduct. Fresenius maintained that they withheld information regarding the risks of overdose because the evidence was only preliminary. The company is accused of concealing this crucial information about GranuFlo side effects, since it never publicized the findings, nor did Fresenius inform health care professionals outside its own network of dialysis centers.
The FDA mandated a Class I recall of GranuFlo and NaturaLyte products following the anonymously leaked memo, noting that inappropriate dosage of either dialysate could result in metabolic alkalosis – a potentially fatal condition in which bicarbonate levels are too high, putting patients at risk for heart attack and other complications, including death.
Status of GranuFlo litigation
In the wake of the 2012 GranuFlo and NaturaLyte recall, an increasing number of dialysis patients have become aware of the link between their injuries – or deaths of loved ones – and Fresenius products. To date, some 732 plaintiffs have filed claims against Fresenius Medical Care, seeking damages for medical expenses, lost wages, diminished earnings capacity, emotional trauma and other losses. The manufacturer has petitioned for multidistrict litigation (MDL), in an effort to centralize all federal GranuFlo lawsuits, but a decision has not been finalized by the U.S. Judicial Panel on Multidistrict Litigation (JPML). In 2012, Fresenius reached a GranuFlo lawsuit settlement for an undisclosed sum with the five surviving children of an Illinois woman who suffered heart failure and died after dialysis at a Fresenius clinic.
Benefits of GranuFlo pre settlement funding
Since it is uncertain how long litigation will proceed before jury verdicts or settlements are reached, many plaintiffs are exploring the advantages of a GranuFlo lawsuit loan. Also known as settlement advance loans, these funds can help claimants stay afloat during financially uncertain times. Don’t be confused by the name, as this type of funding isn’t a loan in the traditional sense. A pre settlement loan is actually a cash advance based on the expected proceeds of your pending lawsuit. You can use this money for any number of purposes: to pay off outstanding medical bills, cover monthly rent, make your mortgage payment, or simply put food on the table. The choice is yours. Many plaintiffs use the cash advance to help fund their cases, enabling their attorneys to secure expert witnesses and fight for a fair settlement.
At LawStreet Capital, we understand that litigation can take years to resolve, leaving plaintiffs saddled with huge debt and forcing many to consider an early settlement. That’s where our dangerous drug lawsuit loans can help. And the best part is, if you don’t win or settle your case, you won’t owe us a dime. Our lawsuit cash advances are known as “non-recourse” loans, meaning there is zero risk to you.
Apply for a GranuFlo lawsuit loan
With LawStreet Capital’s GranuFlo litigation loans, we assume all financial risk based on the strength of your case. Our application process is both free and easy. There are no credit checks, no hidden fees, and no employment verifications. Once approved for a GranuFlo lawsuit loan, you can have your cash in hand in as little as 24 hours. To get started today, please complete the form at the right of your screen, and our representatives will be in touch with you shortly. To learn more about the advantages of pre settlement funding, call LawStreet Capital toll-free at 800-345-8500.